TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07084883: Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration in Ophthalmology and Primary Care Settings

Sponsor: iHealthScreen Inc · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 1076 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07084883 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07084883 Rescue Dossier →